anxiety semaglutide depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy What's Behind The Mental Health – GLP-1 diabetes drugs could stop

Little wonder then that 2024s biggest pharma deal was in the CDMO space Novo Holdings US$ 16.5 billion buyout of Catalent

The results also highlighted potential side effects: about a third of participants reported nausea or diarrhea, while about a quarter reported constipation

Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D

GLP-1s may help with weight management and blood sugar control, whether you take them by injection or by mouth

What is known about the use of weight loss medication in women with overweight/obesity on fertility and reproductive health outcomes

However, retatrutide has not received FDA approval